Results 161 to 170 of about 772,552 (212)

A case of pseudohomozygous type II hyperlipoproteinemia in early infancy

Pediatrics International, 2011
Wataru, Tamaki, Mikiya, Fujieda, Masato, Maeda, Takatoshi, Hosokawa, Hideo, Morita, Tadashi, Asami, Hiroshi, Wakiguchi   +6 more
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Sitosterol in juvenile type II hyperlipoproteinemia

Atherosclerosis, 1978
The effect of beta-sitosterol on plasma lipids and lipoproteins was evaluated in a randomized double-blind cross-over trial in 15 children and adolescents with familial hypercholesterolemia over a period of 6 months. Twelve patients completed the study, with good adherence to drug intake.
G, Schlierf, P, Oster, C C, Heuck, H, Raetzer, B, Schellenberg   +4 more
openaire   +2 more sources

Results of colestipol therapy in type II hyperlipoproteinemia

Atherosclerosis, 1976
Twenty-five patinets with well defined Type ii hyperlipoproteinemia were treated with a divided 15 g daily dose of colestipol, a bile acid sequestrant, for periods of up to 20 months. The patients were divided into 3 groups: Those with no obvious sequelae, those with arcus corneae, xanthomas, and/or xanthelasmas only, and those with atherosclerotic ...
A M, Lees, M A, McCluskey, R S, Lees
openaire   +2 more sources

Pediatric familial type II hyperlipoproteinemia: therapy with diet and cholestyramine resin.

Pediatrics, 1973
Effects of a low cholesterol (
C. Glueck, R. Fallat, R. Tsang
semanticscholar   +1 more source

Effect of lovastatin on hemorheology in type II hyperlipoproteinemia

Atherosclerosis, 1990
To assess the effect of lovastatin on blood rheology, the hemorheological determinants fibrinogen, red cell aggregation, plasma viscosity, hematocrit and platelet aggregation (spontaneous and ADP-induced) were studied in 15 patients with type II hyperlipoproteinemia in the course of treatment with lovastatin.
R, Koppensteiner, E, Minar, H, Ehringer
openaire   +2 more sources

Neonatal Diagnosis of Familial Type II Hyperlipoproteinemia

Pediatrics, 1976
Cord serum prebeta-β-lipoprotein concentrations, was measured in a radial immunodiffusion assay in 303 randomly selected, full-term infants whose parental phenotypes were unknown. Six infants had elevated concentrations, that is above a cut-off limit of 197 mg/100 ml (97.5th percentile).
G E, Andersen, B, Friis-Hansen
openaire   +2 more sources

Therapeutic failure in familial type II hyperlipoproteinemia

Metabolism, 1976
The extended use of diet and cholestyramine therapy in familial type II hyperlipoproteinemia was examined in patients who previously participated in a short-term, double-blind trial. A striking secondary failure in therapeutic response during 4 yr of use of this therapy was noted with plasma cholesterol rising an average of 15%.
L A, Witters, P N, Herbert, R S, Shulman, R M, Krauss, R I, Levy   +4 more
openaire   +2 more sources

Treatment of type II hyperlipoproteinemia with d-thyroxine

Atherosclerosis, 1976
The effectiveness of a new, almost l-thyroxine free preparation of d-thyroxine (Dynothel) was tested in 15 patients with Type IIa and 4 patients with Type IIb hyperlipoproteinemia. Eleven patients with Type IIa and 3 with Type IIb were responsive to treatment and showed an average 26% decrease in plasma TC. This decrement in plasma TC was mirrored in a
A D, Rakow, H U, Klor, E, Kuter, H H, Ditschuneit, H, Ditschuneit   +4 more
openaire   +2 more sources

Secondary type II hyperlipoproteinemia in patients with anorexia nervosa

Metabolism, 1978
In 18 patients with anorexia nervosa, plasma cholesterol and triglyceride concentral concentrations were repeatedly determined over a period of 14 mo. In 11 patients elevated cholesterol concentrations were found which were due to an increase of low-density lipoprotein cholesterol, whereas high-density lipoprotein and very low density lipoprotein ...
R, Mordasini, G, Klose, H, Greten
openaire   +2 more sources

Elevated levels of sphingolipids in type II (a+b) hyperlipoproteinemia

Thrombosis Research, 1974
Abstract The levels of sphingomyelin, neutral glycosphingolipids and gangliosides were studied in normal and type II hyperproteinemic plasmas. Sphingomyelin levels were elevated and there was an excellent correlation between cholesterol and sphingomyelin (r=0.86). The correlation between cholesterol and the remainder of the phospholipids (i.e., total
T B, Auran, J H, Zavoral, W, Krivit
openaire   +2 more sources